Handok Pharmaceuticals

Activities: Manufacturing Cardiovascular Pharmaceutical

Trending Articles

  1. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector...
  2. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making...
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical...
  5. Olon releases its annual ESG report The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in...

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Teva-Handok appoints Yoo Suk Hong as Chief Executive

Teva-Handok is scheduled to launch officially in September
Finance

Teva to establish business venture in Korea with Handok

First commercial deal for Teva in East Asian territory outside Japan
Subscribe now